FindTrial
Sign In

Modafinil for the Treatment of Cocaine Dependence - 1

Modafinil for the Treatment of Cocaine Dependence

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00100100
Enrollment
210
Registered
2004-12-23
Start date
2004-10-31
Completion date
2006-12-31
Last updated
2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Keywords

cocaine dependence

Brief summary

The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Detailed description

This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.

Interventions

DRUGModafinil

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
DIAGNOSTIC

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID. * Must be seeking treatment for cocaine dependence. * Must be able to understand and provide written informed consent.

Exclusion criteria

* Please contact the study site for more information.

Design outcomes

Primary

MeasureTime frame
Cocaine abstinence—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026